SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.

NCT03131154 PHASE3 COMPLETED Results posted

A Phase 3, randomized, double-masked, vehicle-controlled trial to evaluate the safety and efficacy of ADX-102 ophthalmic solution in Subjects with non-infectious anterior-uveitis.

Details

Lead sponsor	Aldeyra Therapeutics, Inc.
Phase	PHASE3
Status	COMPLETED
Enrolment	123
Start date	Wed Apr 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Apr 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Non-infectious Anterior Uveitis

Interventions

• ADX-102 Ophthalmic Solution (0.5%)
• Vehicle of ADX-102 Ophthalmic Solution

Countries

United States